Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,829.56
(
-0.08%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: BTH post# 179127

Wednesday, 06/11/2014 8:49:28 PM

Wednesday, June 11, 2014 8:49:28 PM

Post# of 257268
CRIS

So, now theyre stuck with DLBCL when other companies are now getting multiple CRs in early studies in this indication.

Based on slide 10 of their most recent presentation (http://www.curis.com/images/stories/pdfs/Curis_Corporate_Overview.pdf ), CRIS will also be testing CUDC-907 in a Phase 1b trial in a subpopulation of breast cancer patients in 2H14. Not sure what specific sub-group they plan to test the drug in.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today